NASDAQ
ArriVent BioPharma, Inc. Common Stock (AVBP) has a current ratio of 12.83x as of Monday, May 25, 2026. This represents a 29.08% decrease compared to its 12-month average of 18.09x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.